Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.570
+0.270 (11.74%)
At close: Aug 7, 2026, 4:00 PM EDT
2.308
-0.262 (-10.19%)
Pre-market: Aug 10, 2026, 8:48 AM EDT
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 12 employees as of December 31, 2025. The number of employees increased by 2 or 20.00% compared to the previous year.
Employees
12
Change (1Y)
2
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$1,175,551
Market Cap
7.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 2 | 20.00% |
| Dec 31, 2024 | 10 | -3 | -23.08% |
| Dec 31, 2023 | 13 | -2 | -13.33% |
| Dec 31, 2022 | 15 | 0 | - |
| Dec 31, 2021 | 15 | 1 | 7.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Imunon | 20 |
| BioVie | 13 |
| Ensysce Biosciences | 10 |
| AEON Biopharma | 8 |
| Immuron | 7 |
| Alzamend Neuro | 6 |
| Can-Fite BioPharma | 5 |
PCSA News
- 12 days ago - Processa buys Vidya Therapeutics, raises $200 million for drug trials - Reuters
- 12 days ago - Processa Pharmaceuticals Transcript: M&A announcement - Transcripts
- 12 days ago - Processa Pharmaceuticals Press release: M&A announcement - Filings
- 12 days ago - Processa Pharmaceuticals Slides: M&A announcement - Filings
- 12 days ago - Processa Pharmaceuticals acquires Vidya Therapeutics in stock-for-stock deal - TheFly
- 12 days ago - PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. - GlobeNewsWire
- 7 weeks ago - Processa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 3 months ago - Processa Pharmaceuticals Quarterly report: Q1 2026 - Filings